Wee G et al. |
Inheritable histone H4 acetylation of somatic chromatins in cloned embryos. |
2006 |
J. Biol. Chem. |
pmid:16371357
|
Hsu MC et al. |
HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. |
2006 |
J. Biol. Chem. |
pmid:16377629
|
Majumder S et al. |
Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins. |
2006 |
J. Cell. Biochem. |
pmid:16329111
|
Kurschat P et al. |
Neuron restrictive silencer factor NRSF/REST is a transcriptional repressor of neuropilin-1 and diminishes the ability of semaphorin 3A to inhibit keratinocyte migration. |
2006 |
J. Biol. Chem. |
pmid:16330548
|
Zhou H et al. |
Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. |
2006 |
Am. J. Hum. Genet. |
pmid:17033962
|
Suzuki M et al. |
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. |
2006 |
Oncogene |
pmid:16331260
|
Ooi L et al. |
BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression. |
2006 |
J. Biol. Chem. |
pmid:17023429
|
Gaymes TJ et al. |
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis? |
2006 |
Mol. Cancer Res. |
pmid:16877702
|
Malone CS et al. |
B29 gene silencing in pituitary cells is regulated by its 3' enhancer. |
2006 |
J. Mol. Biol. |
pmid:16920149
|
Herman D et al. |
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. |
2006 |
Nat. Chem. Biol. |
pmid:16921367
|
Topark-Ngarm A et al. |
CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. |
2006 |
J. Biol. Chem. |
pmid:16950772
|
Bates EA et al. |
Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. |
2006 |
J. Neurosci. |
pmid:16525063
|
Chuang HC et al. |
Histone deacetylase 3 binds to and regulates the GCMa transcription factor. |
2006 |
Nucleic Acids Res. |
pmid:16528103
|
Hsiao CH et al. |
Fetal hemoglobin induction by histone deacetylase inhibitors involves generation of reactive oxygen species. |
2006 |
Exp. Hematol. |
pmid:16543060
|
Yamamoto G et al. |
Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma. |
2006 |
Virchows Arch. |
pmid:16416296
|
D'Andrea M et al. |
Protein kinase C theta co-operates with calcineurin in the activation of slow muscle genes in cultured myogenic cells. |
2006 |
J. Cell. Physiol. |
pmid:16419034
|
Akiyama T et al. |
Inadequate histone deacetylation during oocyte meiosis causes aneuploidy and embryo death in mice. |
2006 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16651529
|
Kwon O et al. |
NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. |
2006 |
Carcinogenesis |
pmid:16774937
|
Zhao YM et al. |
Effects of histone deacetylase inhibitors on transcriptional regulation of the hsp70 gene in Drosophila. |
2006 |
Cell Res. |
pmid:16775628
|
Sharma D et al. |
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. |
2006 |
Cancer Res. |
pmid:16778215
|
Sato TA and Mitchell MD |
Molecular inhibition of histone deacetylation results in major enhancement of the production of IL-1beta in response to LPS. |
2006 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:16234266
|
Wu Y and Guo SW |
Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780. |
2006 |
Gynecol. Obstet. Invest. |
pmid:16778450
|
Iacomino G et al. |
Effects of histone deacetylase inhibitors on p55CDC/Cdc20 expression in HT29 cell line. |
2006 |
J. Cell. Biochem. |
pmid:16795040
|
Vanniasinkam T et al. |
Trichostatin-A enhances adaptive immune responses to DNA vaccination. |
2006 |
J. Clin. Virol. |
pmid:16765083
|
El-Zawahry A et al. |
In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL. |
2006 |
Cancer Gene Ther. |
pmid:16167063
|
Yu Z and Kone BC |
Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. |
2006 |
Am. J. Physiol. Renal Physiol. |
pmid:16174862
|
Kozłowska A and Jagodziński PP |
Effect of Trichostatin A on CD4 surface density in peripheral blood T cells. |
2006 |
Folia Histochem. Cytobiol. |
pmid:17219719
|
He J et al. |
Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. |
2006 |
J. Huazhong Univ. Sci. Technol. Med. Sci. |
pmid:17219959
|
Wang Q et al. |
Histone phosphorylation and pericentromeric histone modifications in oocyte meiosis. |
2006 |
Cell Cycle |
pmid:16969090
|
Karvonen U et al. |
Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. |
2006 |
Exp. Cell Res. |
pmid:16860317
|
Wagner S et al. |
SET-mediated promoter hypoacetylation is a prerequisite for coactivation of the estrogen-responsive pS2 gene by PRMT1. |
2006 |
J. Biol. Chem. |
pmid:16861234
|
Zhang X et al. |
Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. |
2006 |
Oncol. Rep. |
pmid:16865256
|
Lund P et al. |
Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. |
2006 |
Oncogene |
pmid:16568090
|
Piacentini P et al. |
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. |
2006 |
Virchows Arch. |
pmid:16568310
|
Alao JP et al. |
The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines. |
2006 |
Mol. Cancer |
pmid:16503970
|
Alao JP et al. |
Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells. |
2006 |
Mol. Cancer |
pmid:16504004
|
Ostapkowicz A et al. |
Lipid rafts remodeling in estrogen receptor-negative breast cancer is reversed by histone deacetylase inhibitor. |
2006 |
Mol. Cancer Ther. |
pmid:16505096
|
Hellebrekers DM et al. |
Angiostatic activity of DNA methyltransferase inhibitors. |
2006 |
Mol. Cancer Ther. |
pmid:16505122
|
Kong X et al. |
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. |
2006 |
Mol. Cell. Biol. |
pmid:16507982
|
Cecconi D et al. |
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. |
2005 Nov-Dec |
J. Proteome Res. |
pmid:16335935
|
Garcia BA et al. |
Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. |
2005 Nov-Dec |
J. Proteome Res. |
pmid:16335948
|
Kook SH et al. |
Epstein-Barr virus-infected Akata cells are sensitive to histone deacetylase inhibitor TSA-provoked apoptosis. |
2005 |
J. Biochem. Mol. Biol. |
pmid:16336792
|
Chen LJ et al. |
[hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:16403252
|
Liu H et al. |
[Antineoplastic effect of valproic acid and trichostatin on HL-60 and K562 cells]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:16403260
|
Burlibaşa L and Gavrilă L |
Molecular and ultrastructural studies of the sperm chromatin from Triturus cristatus. |
2005 |
Zygote |
pmid:16261764
|
Marengo E et al. |
Use of Legendre moments for the fast comparison of two-dimensional polyacrylamide gel electrophoresis maps images. |
2005 |
J Chromatogr A |
pmid:16301071
|
Juranek SA et al. |
snRNA and heterochromatin formation are involved in DNA excision during macronuclear development in stichotrichous ciliates. |
2005 |
Eukaryotic Cell |
pmid:16278460
|
Chang CW et al. |
Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. |
2005 |
Mol. Cell. Biol. |
pmid:16166624
|
Jori FP et al. |
RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells. |
2005 |
Cell Death Differ. |
pmid:15459751
|
Xu CR et al. |
Histone acetylation affects expression of cellular patterning genes in the Arabidopsis root epidermis. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16176989
|
Wu P et al. |
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor. |
2005 |
Biochem. Biophys. Res. Commun. |
pmid:16051188
|
Yaneva M et al. |
Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor. |
2005 |
Nucleic Acids Res. |
pmid:16177181
|
Kang JE et al. |
Histone deacetylase-1 represses transcription by interacting with zinc-fingers and interfering with the DNA binding activity of Sp1. |
2005 |
Cell. Physiol. Biochem. |
pmid:16121030
|
Chen CS et al. |
Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes. |
2005 |
J. Biol. Chem. |
pmid:16186112
|
Bradbury CA et al. |
Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. |
2005 |
Leukemia |
pmid:16121216
|
Cismasiu VB et al. |
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. |
2005 |
Oncogene |
pmid:16091750
|
Fang MZ et al. |
Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. |
2005 |
Clin. Cancer Res. |
pmid:16203797
|
GarcÃa-Morales P et al. |
Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines. |
2005 |
Mol. Cancer Ther. |
pmid:16093438
|
Menegola E et al. |
Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. |
2005 |
Birth Defects Res. B Dev. Reprod. Toxicol. |
pmid:16193500
|
Nome RV et al. |
Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. |
2005 |
Mol. Cancer Ther. |
pmid:16093439
|
Liu AL et al. |
[A new target of cancer therapy: advances in the study of histone deacetylase]. |
2005 |
Yao Xue Xue Bao |
pmid:16196262
|
Zhang Y et al. |
Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. |
2005 |
Mol. Cell. Biol. |
pmid:16135786
|
Ren C et al. |
Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. |
2005 |
J. Am. Soc. Mass Spectrom. |
pmid:16099169
|
Shinji C et al. |
Design and synthesis of phthalimide-type histone deacetylase inhibitors. |
2005 |
Bioorg. Med. Chem. Lett. |
pmid:16137884
|
Danaher RJ et al. |
Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. |
2005 |
J. Neurovirol. |
pmid:16036811
|
Laribee RN and Klemsz MJ |
Histone H4 HDAC activity is necessary for expression of the PU.1 gene. |
2005 |
Biochim. Biophys. Acta |
pmid:16139904
|
Blagosklonny MV et al. |
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. |
2005 |
Cancer Res. |
pmid:16103091
|
Choi JH et al. |
Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16141407
|
Krouwels IM et al. |
A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. |
2005 |
J. Cell Biol. |
pmid:16103223
|
Sengupta S et al. |
Tumor suppressor p53 represses transcription of RECQ4 helicase. |
2005 |
Oncogene |
pmid:15674334
|
Busson M et al. |
Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. |
2005 |
Oncogene |
pmid:15674337
|
Wen J et al. |
Tal1/SCL binding to pericentromeric DNA represses transcription. |
2005 |
J. Biol. Chem. |
pmid:15677454
|
Illi B et al. |
Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. |
2005 |
Circ. Res. |
pmid:15705964
|
Jalonen U et al. |
Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. |
2005 |
Biochem. Pharmacol. |
pmid:15710351
|
Schmittwolf C et al. |
In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. |
2005 |
EMBO J. |
pmid:15660132
|
Kang J et al. |
Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. |
2005 |
Toxicol In Vitro |
pmid:15649630
|
Song Y et al. |
[The mechanisms of p21WAF1/Cip-1 expression in MOLT-4 cell line induced by TSA]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15854272
|
Xu ZM et al. |
[Analysis of the methylation in the promoter of LRP15 gene and its expression]. |
2005 |
Zhongguo Shi Yan Xue Ye Xue Za Zhi |
pmid:15854274
|
Mai A et al. |
Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides. |
2005 |
J. Med. Chem. |
pmid:15857140
|
Ho WC et al. |
Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. |
2005 |
Cancer Res. |
pmid:15899819
|
Tran T et al. |
Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. |
2005 |
Cancer Res. |
pmid:15899836
|
Camelo S et al. |
Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. |
2005 |
J. Neuroimmunol. |
pmid:15885809
|
Young DA et al. |
Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. |
2005 |
FEBS J. |
pmid:15819885
|
Canes D et al. |
Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo. |
2005 |
Int. J. Cancer |
pmid:15499627
|
Yamaguchi K et al. |
Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. |
2005 |
J. Biol. Chem. |
pmid:15994313
|
Zhao XY et al. |
Granulocyte-macrophage colony-stimulating factor induces de novo methylation of the p15 CpG island in hematopoietic cells. |
2005 |
Cytokine |
pmid:15996479
|
Sato N et al. |
Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. |
2005 |
Clin. Cancer Res. |
pmid:16000561
|
Munshi A et al. |
Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. |
2005 |
Clin. Cancer Res. |
pmid:16000590
|
Endo T et al. |
Changes in histone modifications during in vitro maturation of porcine oocytes. |
2005 |
Mol. Reprod. Dev. |
pmid:15736133
|
Mori T et al. |
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. |
2005 |
Cancer Res. |
pmid:15753377
|
Dowling M et al. |
Mitotic spindle checkpoint inactivation by trichostatin a defines a mechanism for increasing cancer cell killing by microtubule-disrupting agents. |
2005 |
Cancer Biol. Ther. |
pmid:15753652
|
Dote H et al. |
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour. |
2005 |
Br. J. Cancer |
pmid:15770214
|
Laberge RM and Boissonneault G |
On the nature and origin of DNA strand breaks in elongating spermatids. |
2005 |
Biol. Reprod. |
pmid:15772260
|
McKenzie GJ et al. |
Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. |
2005 |
J. Neurochem. |
pmid:15773917
|
Blais M et al. |
Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter. |
2005 |
DNA Cell Biol. |
pmid:15812237
|
Sato N et al. |
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. |
2005 |
Oncogene |
pmid:15592528
|
Davidson SM et al. |
The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. |
2005 |
Chembiochem |
pmid:15593114
|
Maxhimer JB et al. |
Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). |
2005 |
J. Thorac. Cardiovasc. Surg. |
pmid:15632825
|
Kondo T et al. |
Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. |
2005 |
Oncogene |
pmid:15637589
|
Nambiar MP et al. |
Transcriptional induction of cholinesterase expression and protection against chemical warfare nerve agents. |
2005 |
Chem. Biol. Interact. |
pmid:16429504
|